Le mode conseil est activé Arrêter
Pour la navigation rapide entre les blocs

Organisation: Societal CDMO
LEI 2549004EL1Z016VYWA54

Nom de l'organisation
Societal CDMO Inc (formerly Recro Pharma, Inc.)
Nom du pays
États-Unis
Pays d'enregistrement
États-Unis
Secteur économique
Production de médicaments et biotechnologies
Dette obligataire
-

explorer la base de données la plus complète

800 000

obligations globalement

Plus de 400

sources de prix

80 000

actions

9 000

ETF

suivre votre portefeuille de la manière la plus efficace
screener d'obligations
liste de surveillance
Excel ADD-IN
Obtenir l'accès

Dernières données pour

Cotations

Requête envoyé
Accès refusé
Envoyer la requête
Les cotations fournis par les fournisseurs d’information sont de nature indicative

Profile

Societal CDMO Inc is a specialty pharmaceutical company. The Company develops non-opioid therapeutics for the treatment of pain in the post-operative setting. Societal CDMO offers its products to the medical industry.

Récompenses

Actualités

08/04/2024 Societal CDMO: Of This Current Report On Form, Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard; Transfer Of Listing, Material Modification To Rights Of Security Holders, Changes In Control Of Registrant, Departure Of Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Financial Statements And Exhibits
14/03/2024 Societal CDMO: Other Events
28/02/2024 Societal CDMO: Entry Into A Material Definitive Agreement, Regulation Fd Disclosure, Financial Statements And Exhibits
21/11/2023 Societal CDMO: Entry Into A Material Definitive Agreement, Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard; Transfer Of Listing, Financial Statements And Exhibits
24/08/2023 Societal CDMO: Entry Into A Material Definitive Agreement, Financial Statements And Exhibits
Toutes les actualités de l'organisation

Documents

Etats financiers IFRS / US GAAP

2023
I q ang
II q ang
III q ang
IV q ang
2022
I q ang
II q ang
III q ang
IV q ang
2021
I q ang
II q ang
III q ang
IV q ang
2020
I q ang
II q ang
III q ang
IV q ang
2019
I q ang
II q ang
III q ang
IV q ang
2018
I q ang
II q ang
III q ang
IV q ang
2017
I q ang
II q ang
III q ang
IV q ang
2016
I q ang
II q ang
III q ang
IV q ang
2015
I q ang
II q ang
III q ang
IV q ang
2014
IV q ang
Afficher tout Masquer
Il faut s'enregistrer
Envoyer la demande d'accès accès

Actions

Dette obligataire par devise

Montrer tout Cacher

Codes

  • LEI
    2549004EL1Z016VYWA54
  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
  • CIK
    0001588972
  • EIN
    26-1523233

Notations de crédit et notations d’ESG

Macroéconomie

Vous devez vous inscrire pour y accéder.